Salvatore Calabrese

2020

In 2020, Salvatore Calabrese earned a total compensation of $319.4K as Chief Financial Officer at Gain Therapeutics.

Compensation breakdown

Bonus$21,095
Non-Equity Incentive Plan$25,086
Option Awards$202,253
Salary$41,810
Other$29,116
Total$319,360

Calabrese received $202.3K in option awards, accounting for 63% of the total pay in 2020.

Calabrese also received $21.1K in bonus, $25.1K in non-equity incentive plan, $41.8K in salary and $29.1K in other compensation.

Rankings

In 2020, Salvatore Calabrese's compensation ranked 12,025th out of 13,090 executives tracked by ExecPay. In other words, Calabrese earned more than 8.1% of executives.

ClassificationRankingPercentile
All
12,025
out of 13,090
8th
Division
Manufacturing
5,145
out of 5,621
9th
Major group
Chemicals And Allied Products
2,097
out of 2,254
7th
Industry group
Drugs
1,827
out of 1,954
7th
Industry
Pharmaceutical Preparations
1,357
out of 1,459
7th
Source: SEC filing on May 13, 2022.

Calabrese's colleagues

We found one more compensation record of an executive who worked with Salvatore Calabrese at Gain Therapeutics in 2020.

2020

Eric Richman

Gain Therapeutics

Chief Executive Officer

News

In-depth

You may also like